Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LIFILEUCEL vs LINAGLIPTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LIFILEUCEL vs LINAGLIPTIN: Safety Overview

Metric LIFILEUCEL LINAGLIPTIN
Total FAERS Reports 198 7,762
Deaths Reported 37 726
Death Rate 18.7% 9.4%
Hospitalizations 118 2,794
Average Patient Age 57.1 yrs 70.2 yrs
% Female Patients 46.3% 51.8%
FDA Approval Date N/A Aug 31, 2021
Manufacturer Iovance Biotherapeutics Inc. Novadoz Pharmaceuticals LLC
Route INTRAVENOUS ORAL
Marketing Status N/A Prescription